inflammatory bowel disease
Conditions
Interventions
None listed
Sponsors
Osaka Medical and Pharmaceutical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inpatients with IBD or Inpatients with no pre-existing medical conditions
Exclusion criteria
Exclusion criteria: a) Patients with the following cardiac diseases 1) Patients with congestive heart failure of NYHA class 3 or higher 2) Patients with poorly controlled hypertension b) Patients with serious and active infections (excluding HBV and HCV) c) Patients who have undergone highly invasive surgery within 4 weeks prior to the start of this study d) Pregnant, lactating women and patients who may or intend to become pregnant e) Patients with substance abuse or other health, psychological, or social conditions that would interfere with their participation in this study and the evaluation of its results. f) Any other situation that may compromise patient safety in the conduct of this study or that is deemed difficult to comply with the study protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the presence or absence of sarcopenia and its associated factors (muscle mass, muscle strength, physical function, and biomarker values) due to hospitalization | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of disease activity, relapse rates, and surgical rates, Correlation of sarcopenia and related factors with disease activity, relapse rate, and surgical rate | — |
Countries
Japan
Contacts
Public ContactTAKAKO Miyazaki
Osaka Medical and Pharmaceutical University 2nd Department of Internal Medicine
Outcome results
None listed